肝硬化患者合理使用低分子量肝素的探讨。 - Suppr

Suppr

超能文献

Towards a rational use of low-molecular-weight heparin in patients with cirrhosis.

作者信息

Lisman Ton, Porte Robert J

出版信息

Liver Int. 2011 Aug;31(7):1063. doi: 10.1111/j.1478-3231.2011.02489.x. Epub 2011 Feb 25.

DOI:10.1111/j.1478-3231.2011.02489.x

PMID:21733099

Abstract

摘要

相似文献

Towards a rational use of low-molecular-weight heparin in patients with cirrhosis.

Liver Int. 2011 Aug;31(7):1063. doi: 10.1111/j.1478-3231.2011.02489.x. Epub 2011 Feb 25.

Dosing and monitoring of low-molecular-weight heparin in cirrhotic patients.

Liver Int. 2011 Aug;31(7):1064. doi: 10.1111/j.1478-3231.2011.02548.x. Epub 2011 May 31.

Anticoagulation in cirrhosis patients: what don't we know?

Liver Int. 2011 Jan;31(1):4-6. doi: 10.1111/j.1478-3231.2010.02376.x. Epub 2010 Nov 24.

Low-molecular-weight heparin in patients with advanced cirrhosis.

Liver Int. 2011 Jan;31(1):75-82. doi: 10.1111/j.1478-3231.2010.02358.x. Epub 2010 Oct 20.

Pharmacokinetics of subcutaneous low molecular weight heparin (enoxaparin) in dogs.

J Am Anim Hosp Assoc. 2009 Nov-Dec;45(6):261-7. doi: 10.5326/0450261.

Biomarkers and coagulation tests for assessing the biosimilarity of a generic low-molecular-weight heparin: results of a study in healthy subjects with enoxaparin.

J Clin Pharmacol. 2008 Oct;48(10):1189-96. doi: 10.1177/0091270008322911. Epub 2008 Aug 20.

[On the mechanism of gastrointestinal hemorrhage in liver cirrhosis].

Vestn Khir Im I I Grek. 1968 Feb;100(2):50-2.

Use of thromboelastography to demonstrate persistent anticoagulation after stopping enoxaparin.

Anaesthesia. 2007 Nov;62(11):1175-8. doi: 10.1111/j.1365-2044.2007.05225.x.

Routine laboratory monitoring for low-molecular-weight heparin prophylaxis in burns? Not so fast!

J Burn Care Res. 2011 Jul-Aug;32(4):e155. doi: 10.1097/BCR.0b013e3182223f52.

Screening for esophageal varices among patients with cirrhosis of the liver.

Am J Gastroenterol. 2001 Oct;96(10):3039-40. doi: 10.1111/j.1572-0241.2001.04692.x.

引用本文的文献

Cirrhosis and Coagulopathy: Mechanisms of Hemostasis Changes in Liver Failure and Their Management.

Cureus. 2022 Apr 3;14(4):e23785. doi: 10.7759/cureus.23785. eCollection 2022 Apr.

Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference.

Thromb Haemost. 2018 Aug;118(8):1491-1506. doi: 10.1055/s-0038-1666861. Epub 2018 Jul 30.

Population pharmacokinetics of enoxaparin in early stage of paediatric liver transplantation.

Br J Clin Pharmacol. 2018 Jun;84(6):1206-1214. doi: 10.1111/bcp.13543. Epub 2018 Mar 23.

Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis.

PLoS One. 2017 May 4;12(5):e0177020. doi: 10.1371/journal.pone.0177020. eCollection 2017.

Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays.

Thromb J. 2014 Nov 4;12:24. doi: 10.1186/1477-9560-12-24. eCollection 2014.

Low molecular weight heparin in portal vein thrombosis of cirrhotic patients: only therapeutic purposes?

ScientificWorldJournal. 2014;2014:895839. doi: 10.1155/2014/895839. Epub 2014 Dec 29.

Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review.

World J Gastroenterol. 2014 May 21;20(19):5737-45. doi: 10.3748/wjg.v20.i19.5737.

Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis.

PLoS One. 2014 Feb 4;9(2):e88390. doi: 10.1371/journal.pone.0088390. eCollection 2014.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验